<https://rdf.molmedb.upol.cz/reference/ref3241> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane46>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2018.10.045"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490074>,
		<https://identifiers.org/molmedb/MM490077>;
	<http://purl.org/ontology/bibo/pmid> "30389294"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method71>,
		<https://identifiers.org/molmedb/MM489921>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Liu H, Dai X, He S, Brockunier L, Marcantonio K, Ludmerer SW, Li F, Feng KI, Nargund RP, Palani A.: Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase. Bioorg Med Chem Lett, Volume 29 (24), 2019"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490078> .
<https://rdf.molmedb.upol.cz/interaction/int1009572> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3241> .
<https://rdf.molmedb.upol.cz/interaction/int1009568> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3241> .
<https://rdf.molmedb.upol.cz/interaction/int1009355> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3241> .
<https://rdf.molmedb.upol.cz/interaction/int1009573> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3241> .